The largest database of trusted experimental protocols

Pfc sigma

Manufactured by DePuy
Sourced in United States

The PFC Sigma is a medical device used in orthopedic procedures. It is designed to provide stable fixation and facilitate the healing process. The product's core function is to serve as a component in joint replacement surgeries, assisting in the restoration of joint function.

Automatically generated - may contain errors

11 protocols using pfc sigma

1

Optimal Knee Implant Selection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The femoral and tibial AP and ML values obtained from each patient were compared with the sizes of available knee implants. The femur sizes were compared with PFC Sigma (Depuy, Warsaw, IN, USA), Attune (Depuy), Triathlon (Stryker, Kalamazoo, IN, USA), Nexgen (Zimmer, Warsaw, IN, USA), and Vanguard (Biomet, Warsaw, IN, USA). The tibial sizes were compared with PFC Sigma (Depuy), Attune (Depuy), Nexgen (Zimmer), and Vanguard (Biomet). Scatter graphs were plotted with the patient size and the best possible implant size for all the implants.
+ Open protocol
+ Expand
2

Total Joint Arthroplasty Protocol for Hemophilia Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
One surgical team consisting of 2 senior orthopaedics surgeons performed all TJAs. The surgeons applied a standard posterolateral approach as previously described [10 (link)] for the patients undergoing THA, using the cementless prostheses (DePuy PINNACLE+CORAIL). For patients undergoing TKA, a standard medial parapatellar approach and a measured resection technique were used as previously described [9 (link), 11 (link)], the prosthesis was a cemented total knee system (DePuy Sigma PFC). For patients in the TXA group, TXA was administered as described before [11 (link)]. Briefly, all patients in the TXA group received intravenous TXA 5 to 10 min before the skin incision (20 mg/kg) and 3, 6, 12, and 24 h later (10 mg/kg) along with 1 g of topical TXA in 50 mL of normal saline solution. Tourniquet was used in all patients undergoing TKA. The surgeons applied the same modern perioperative pain control, clinical and rehabilitation protocols in all patients as previously described [9 (link)–11 (link)]. Considering the characteristic of haemophilia patient, only mechanical methods including compression elastic stockings and intermittent pneumatic compression were used for prophylaxis.
+ Open protocol
+ Expand
3

Quantifying Knee Prosthesis and Bone Cement

Check if the same lab product or an alternative is used in the 5 most similar protocols
We defined bone and soft tissues removed during the operation as the removed material and the knee prosthesis and bone cement as the implanted material. The removed material and residual polymerized cement were collected using two specimen bags during the operation and then weighed using a precision electronic balance with an accuracy of 0.0001 g (Fig. 1c-d). The manufacturers provided the weight of the specimen bags, prostheses, and one full bottle of cement. The weight of the bone cement in the whole bottle minus the weight of the unused cement was calculated as the weight of the used bone cement. We defined the change of the knee joint weight as the total weight of the implanted material minus the total weight of the removed material.
In order to eliminate the influence of different implants on the postoperative efficacy of patients, all knees received cruciate-retaining (CR) implants (Sigma PFC®, DePuy, America). Otherwise, patients were excluded from this study. The femoral and tibial parts of the prostheses of this brand were made of cobalt-chromium (Co-Cr) alloy, and the spacer was made of highly cross-linked polyethylene.
+ Open protocol
+ Expand
4

Comparative Analysis of TKA Prostheses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Retrospective analysis of the results of two groups of patients operated by the same surgeon by two primary PS TKA systems, PFC Sigma (DePuy Synthes, Johnson and Johnson®) and Genesis II prosthesis (Smith and Nephew®), with an average of five year follow-up was done. The demographic data of the patients including the preoperative co-morbidities are shown in (Table 1).

Demographic data of the patients

VariableGroup 1 (152 knees)Group 2 (122 knees)p-value
Age (years)68.2 ± 6.5, (55–81)67.1 ± 6, (56–80)0.151
Male/female41/11135/871.000
Duration of follow-up (years)5.2 ± 2.1, (3.5–6.2)5.0 ± 2, (3.2–5.6)0.424
Body mass index28.1 ± 2.527.8 ± 3.10.387

Preoperative co-morbidities*

Hypertension

Diabetes

Heart disease

Thyroid disease

Chronic kidney disease

BPH

Spinal decompression

Lupus erythematosus

Previous cancer colon

Previous breast cancer

Post-phlebitic limb

Depression

83

74

62

13

8

5

3

0

1

2

1

10

67

45

34

10

7

5

4

2

0

3

0

11

*Heart disease includes patients with previous coronary bypass grafting; chronic kidney patients do not include patients with dialysis; previous spinal decompression patients do not include patients with radicular lower limb pain

Power analysis was carried out in advance and the study protocol was reviewed and approved by our institutional review board and ethical committee (#5486, November 2023). All patients provided their written informed consents to participate in this study.
+ Open protocol
+ Expand
5

Revision Knee Arthroplasty Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the primary group, nine patients had a PFC Sigma (DePuy Synthes, West Chester, Pennsylvania, USA) and two had a Triathlon (Stryker, Kalamazoo, Michigan, USA). In the fibrosis cohort, the primary knee arthroplasties were PFC Sigma in four cases, Triathlon in two, and Kinemax (Stryker Howmedica Osteonics, Mahwah, New Jersey, USA) in two. Four of the eight cases in this group had had the patella resurfaced during the primary procedure. In the non-fibrotic revision cohort the primary knee arthroplasties were PFC Sigma in two, Triathlon in one, and Kinemax in two. Revisions were performed using the NexGen rotating hinge (ZimmerBiomet, Warsaw, Indiana, USA; five cases), LCCK (ZimmerBiomet; five cases), and TC3 (DePuy Synthes; three cases).
In all primary and revision TKA patients, local anaesthetic was administered intraoperatively under direct vision (to a maximum dose of 100 ml of 0.2% ropivacaine). All patients were given routine postoperative analgesia, including regular paracetamol and a patient-controlled analgesia device. Patients in the fibrotic revision group were routinely started on continuous passive movement for 48 to 72 hours postoperatively.
+ Open protocol
+ Expand
6

Nationwide TKA Registry Data Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
LROI TKA register data up to January 1, 2020 was obtained. All patients with primary osteoarthritis aged 18 years or older, with a primary TKA between January 1, 2014 and December 31, 2019, and who had PROM questionnaires available at all timepoints, were included. We included the 4 most commonly used TKA implants in the Netherlands: Genesis II (Smith and Nephew, Memphis, TN, USA), Nexgen (Zimmer Biomet, Warsaw, IN, USA), Vanguard (Zimmer Biomet, Warsaw, IN, USA), PFC/Sigma (DePuy Synthes, Warsaw, IN, USA). These total knee systems comprise 72% of all total knee implants used in the Netherlands between 2014 and 2019. The fifth most-used knee prosthesis in the Netherlands was the LCS (DePuy Synthes, Raynham, MA, USA); as only a limited proportion of patellae were resurfaced with this prosthesis (2.5%) and as it is no longer produced, the LCS was excluded from analysis.
+ Open protocol
+ Expand
7

Cementless THA and Cemented TKA

Check if the same lab product or an alternative is used in the 5 most similar protocols
All operations were performed in a single Department of Orthopaedic Surgery of a University Medical Centre. The lateral decubitus position was used for the cementless THA. A minimally invasive anterolateral approach was chosen [12 ]. Press-fit acetabular components and cementless stems from a single manufacturer (Pinnacle cup, Corail or Trilock stem; DePuy, Warsaw, IN) were used in all THAs. The cemented TKA was performed via a medial parapatellar approach. Cemented components from a single manufacturer (PFC Sigma; DePuy) were used in all TKAs. Patella resurfacing was not performed.
+ Open protocol
+ Expand
8

Multimodal Knee Arthroplasty Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cases utilized a medial parapatellar incision and a multimodal pain management regimen. All patients were mobilized as soon as possible with no restrictions. Conventional implants (January 2008–December 2010) included the following models: Genesis 2 (Smith & Nephew), Sigma (DePuy), and PFC Sigma (DePuy). The PSI groups (January 2011–June 2013) received the ConforMIS iTotal G2 implant.
+ Open protocol
+ Expand
9

Prosthetic Knee Compatibility with Filipino Anatomy

Check if the same lab product or an alternative is used in the 5 most similar protocols
The currently available prostheses in the Philippine and Asian markets were reviewed. The dimensions of the prostheses and knees were plotted. The best fit line was used to observe the fitness of each prosthesis vis-à-vis the dimensions of the Filipino knee. The following implants were used for comparison: (1) Advance MPK (Microport Orthopedics, TN, USA); (2) Axis Knee (DOST-PCHRD, Philippines); (3) Duracon (Stryker Corp., MI, USA); (4) Gemini (Waldemar Link GmbH & Co., Germany); (5) Genesis II and Legion (Smith and Nephew, UK); (6) PFC Sigma (DePuy-Synthes, IN, USA); (7) Scorpio (Stryker Corp., MI, USA); and (8) U2 Knee (United Orthopaedics Corp., Taiwan). The aspect ratios of these prostheses were respectively based on the specifications provided by their corresponding companies.
+ Open protocol
+ Expand
10

Unilateral Cemented TKA with Femoral Nerve Block

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients underwent TKA with general anesthesia and a femoral nerve block. We performed unilateral cemented TKA (posterior-stabilized, n = 58; cruciate-retaining, n = 37; cruciate-substituting, n = 5) using a medial parapatellar or midvastus approach with a femoral tourniquet (300 mmHg). The types of implants used were the P.F.C. SIGMA (Depuy Synthes, Raynham, MA, USA) in 90 patients, Bi-Surface (Kyocera Medical Corporation, Osaka, Japan) in 3, Triathlon (Stryker Corporation, Kalamazoo, MI, USA) in 3, Vanguard (Zimmer Biomet, Warsaw, IN, USA) in 2, and Columbus (B/Braun Aesculap Implant Systems, Center Valley, PA, USA) in 2. A suction drain was placed in the joint. For postoperative pain management, the patients underwent placement of femoral nerve catheters with continuous infusion of 0.2% ropivacaine and oral administration of nonsteroidal anti-inflammatory drugs or acetaminophen. The femoral nerve catheter and suction drain were removed 2 days after surgery. All patients received antithrombotic treatment (edoxaban, a factor Xa inhibitor) for 2 weeks from the day after the operation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!